Rapid Micro Biosystems to Announce Third Quarter 2025 Financial Results on November 7, 2025

Rhea-AI Summary

Rapid Micro Biosystems (Nasdaq: RPID) will release third quarter 2025 financial results before market open on Friday, November 7, 2025.

The company's management will host a webcast conference call at 8:30 a.m. ET on November 7, 2025 to discuss results; the live audio webcast is accessible on the company website and will be archived for replay.

LEXINGTON, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release third quarter 2025 financial results prior to the market open on Friday, November 7, 2025.

In conjunction with the release, the Company’s management team will host a webcast conference call at 8:30 a.m. ET on Friday, November 7, 2025. The live audio webcast will be accessible on the Company’s website and can be accessed with this link. The webcast will be archived and available for replay after the event.

About Rapid Micro Biosystems

Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company’s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (“MQC”) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit www.rapidmicrobio.com or follow the Company on X (formerly known as Twitter) at @rapidmicrobio or on LinkedIn. 

Investor Contact:
Michael Beaulieu, CFA
Vice President, Investor Relations and Corporate Communications
investors@rapidmicrobio.com

Media Contact:
media@rapidmicrobio.com

FAQ

When will Rapid Micro Biosystems (RPID) report Q3 2025 results?

Rapid Micro Biosystems will release Q3 2025 financial results before market open on November 7, 2025.

What time is the RPID Q3 2025 earnings webcast on November 7, 2025?

The management webcast conference call is scheduled for 8:30 a.m. ET on November 7, 2025.

Where can I listen to the Rapid Micro Biosystems (RPID) November 7, 2025 webcast?

The live audio webcast will be accessible on Rapid Micro Biosystems' investor website and will be archived for replay after the event.

Will the RPID Q3 2025 webcast be available for replay after November 7, 2025?

Yes. The webcast will be archived on the company's website and available for replay after the event.

Is Rapid Micro Biosystems (RPID) issuing guidance with the Q3 2025 release on November 7, 2025?

The announcement only schedules the Q3 2025 results release and webcast; any guidance would be disclosed during the earnings release or call.

How can investors access the RPID live audio webcast link for November 7, 2025?

Investors can access the live audio webcast via the Rapid Micro Biosystems investor relations website using the provided webcast link.